Nts whose relapse was treated with first-line tamoxifen monotherapy. These patients had not received (neo) adjuvant endocrine systemic treatment. In univariate analyses, no statistically significant associations were observed between DC-SCRIPT as transformed continuous variable and PFS or clinical benefit after start of first-line treatment with tamoxifen (HR = 1.08 [0.99 to 1.18], P = 0.07 and od

CARSSEO is an open source content management system that lets you easily create your own user-powered website.

Latest Comments